acamprosate

acamprosate
Trade Name
Orphan Indication Fragile X syndrome
USA Market Approval USA
USA Designation Date 2013-03-25 00:00:00
Sponsor Confluence Pharmaceuticals, LLC;Box 528, 351 West 10th Street;Indianapolis, Indiana, 46202